Swiss Biotech Day 2025
May 5-6, 2025 | Basel, Switzerland
We are excited to announce that we will sponsor, attend, and speak at Swiss Biotech Day, a premier biotechnology conference in Europe that attracts professionals from the global life sciences community.
Be sure to attend our panel “From Lab to Market: The Investor-Innovator Dynamic in Biotech” and connect with our delegates on-site to discover how we can assist you with our agile and holistic biotech solutions.
About Our Panel “From Lab to Market: The Investor-Innovator Dynamic in Biotech”
May 5, 15:30 – 16:15, room Marriott 3+4+5
Biotech innovation is a high-stakes game where ideas meet funding limits. In 2025, shifting investment cycles—from the metabolic disease boom to struggles in cell and gene therapies—reshape the landscape. Macroeconomic and political forces, including U.S. research funding shifts and Europe’s fragmented capital markets, add complexity. This panel explores how investors filter opportunities, which biotech sectors rise or fall, and what it takes to secure investment.
Speakers:
- Joris Pezzini, Executive Vice President, Biopharma at Alira Health
- Pascale Eede, Associate at Apollo Health Ventures
- Pierre Morgon, CEO at Ibex Therapeutics
- Massimo Mineo, CEO at Neurolieve Biosciences Ltd, General Partner at Sunrise Venture Capital
- Kevin Hammon, Vice President at EQT Life Science
Meet Our Speaker
Joris Pezzini
Executive Vice President, Biopharma
Joris has more than 15 years of experience as an executive in the healthcare industry, with both science and business roles at biotech, pharma, and consulting firms.
Prior to joining Alira Health, Joris was the Head of Business Development at UCB Pharma, Executive Vice President of Strategy and Business Development at LFB and held a range of scientist roles at biotech firms in the U.S. and UK. Joris is a biotech engineer and received a business and leadership degree from Harvard Business School.
Meet Our Delegates
Marie-Aude Ohresser
Senior Vice President, Regulatory Affairs
Tabatha Bourgois
Business Development Director, Regulatory Affairs
Andrea Mantovani
Partner, Integrated Evidence Consulting
Svetlana Fedorycheva
Clinical Research Associate
Our Latest Biotech Insights
Interview
This interview explores how biotech companies can successfully implement this integrated approach in rare diseases.
Article
This article outlines the current understanding of the HTAR’s effect on HTA processes in France.
Want to connect at Swiss Biotech Day 2025? Contact us to set up a meeting!
Subscribe to our newsletter for the latest news, events, and thought leadership